NASDAQ

Lyell Immunopharma, Inc. (LYEL)

♥ 551 Thanks from members

Live price chart, market sentiment, and community perspectives for Lyell Immunopharma, Inc. (NASDAQ: LYEL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Rick KlausnerFounder: Jason CusterFounder: Stan RiddellLeadership: Richard Klausner (CEO)Leadership: Daniel Calvo (COO)Holder: Arch Venture PartnersHolder: Vanguard GroupHolder: BlackRockReprogrammable T-cell TherapiesGenetically Enhanced Cells#LYEL#Lyell Immunopharma#Cell Therapy#Biotech#NASDAQ